Report cover image

Sinovac Biotech Ltd - Strategic SWOT Analysis Review

Publisher GlobalData
Published May 04, 2026
Length 34 Pages
SKU # GBDT21162427

Description

Sinovac Biotech Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of human vaccines and related products with focus on disease prevention and control. Its product portfolio includes vaccines for COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, and mumps. Sinovac Biotech's vaccines are used in the healthcare industry for disease prevention and control. While the company primarily operates in China, it also supplies vaccines to other countries in Asia, Africa, the Mediterranean region, and Central America. Sinovac Biotech is headquartered in Beijing, China.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

34 Pages
Section 1 - About the Company
Sinovac Biotech Ltd - Key Facts
Sinovac Biotech Ltd - Key Employees
Sinovac Biotech Ltd - Key Employee Biographies
Sinovac Biotech Ltd - Major Products and Services
Sinovac Biotech Ltd - History
Sinovac Biotech Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Section 2 – Company Analysis
Company Overview
Sinovac Biotech Ltd - Business Description
R&D Overview
Sinovac Biotech Ltd - SWOT Analysis
SWOT Analysis - Overview
Sinovac Biotech Ltd - Strengths
Sinovac Biotech Ltd - Weaknesses
Sinovac Biotech Ltd - Opportunities
Sinovac Biotech Ltd - Threats
Sinovac Biotech Ltd - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Sinovac Biotech Ltd, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jan 04, 2026: Sinovac Receives Nasdaq Notice Over Late Filing of 2025 Half-Year Report
Jan 04, 2026: Antigua Court Makes Interim Order Giving Board Control of the Company Until the Trial of the Disputed 2025 Shareholder Meeting
Jan 04, 2026: SINOVAC Secures Exclusive 2026 Influenza Vaccine Supply Contract in Chile
Dec 17, 2025: Sinovac: Antigua Court Orders Interim Board Control Until Trial of Disputed 2025 Shareholder Meeting
Jul 10, 2025: Newly Elected Directors of Sinovac Hold the First Board Meeting
Jul 09, 2025: SINOVAC Board of Directors Strongly Denounces Deceptive and Illegal Claims by SAIF and the Imposter Former Board
Jun 23, 2025: SINOVAC Board of Directors Files Investor Presentation Outlining Decisive Actions to Protect Shareholder Interests
Mar 28, 2025: SINOVAC Announces New Board Member and Chairman of the Audit Committee
Feb 28, 2025: SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
Jan 16, 2025: Sinovac Issues Statement Regarding Privy Council Judgment
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Sinovac Biotech Ltd, Key Facts
Sinovac Biotech Ltd, Key Employees
Sinovac Biotech Ltd, Key Employee Biographies
Sinovac Biotech Ltd, Major Products and Services
Sinovac Biotech Ltd, History
Sinovac Biotech Ltd, Subsidiaries
Sinovac Biotech Ltd, Affiliate
Sinovac Biotech Ltd, Key Competitors
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Sinovac Biotech Ltd, Recent Deals Summary
List of Figures
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us